From The American Society of Plastic Surgeons:
ARLINGTON HEIGHTS, Ill. – The plastic surgery market continues to show significant growth – two years in a row. According to statistics released today by the American Society of Plastic Surgeons (ASPS), 13.8 million cosmetic plastic surgery procedures (both surgical and minimally-invasive) were performed in the United States in 2011, up 5 percent since 2010. In addition, 5.5 million reconstructive plastic surgery procedures were performed last year, up 5 percent.
“While the rate of economic recovery in the U.S. is still uncertain, 2011 proved to be a good year for plastic surgery,” said the ASPS President. “Consumer confidence was up, auto sales rose 10 percent, so it is not surprising that we would also see increased demand for plastic surgery procedures.”
Cosmetic surgical procedures increased 2 percent, with nearly 1.6 million procedures in 2011. The top five surgical procedures were:
• Breast augmentation (307,000 procedures, up 4 percent)
• Nose reshaping (244,000 procedures, down 3 percent)
• Liposuction (205,000 procedures, up 1 percent)
• Eyelid surgery (196,000 procedures, down 6 percent)
• Facelift (119,000 procedures, up 5 percent)
Facelifts are among the top five cosmetic surgical procedures for the first time since 2004, replacing tummy tucks. Interestingly, a procedure popular with men, chin augmentation, nearly doubled in 2011, with 21,000 procedures performed, up 71 percent. Lip augmentation also rose significantly – up 49 percent, with more than 25,000 procedures performed.
Cosmetic minimally-invasive procedures increased 6 percent, with nearly 12.2 million procedures in 2011. The top five minimally-invasive procedures were:
• Botulinum toxin type A (5.7 million procedures, up 5 percent)
• Soft tissue fillers (1.9 million procedures, up 7 percent)
• Chemical peel (1.1 million procedures, down 3 percent)
• Laser hair removal (1.1 million procedures, up 15 percent)
• Microdermabrasion (900,000 procedures, up 9 percent)
Soft tissue fillers like hyaluronic acid (Restylane®, Juvederm Ultra®, etc.), calcium hydroxylapatite (Radiesse®), and fat injections experienced some of the largest growth in the minimally-invasive market during 2011. More than 1.3 million hylauronic acid procedures were performed in 2011, up 9 percent; 286,000 calcium hydroxylapatite procedures, up 36 percent; and 68,000 fat injections, up 19 percent.
Reconstructive plastic surgery, which improves function and appearance to abnormal structures, increased 5 percent in 2011. The top five reconstructive procedures were:
• Tumor removal (4.2 million, up 3 percent)
• Laceration repair (303,000, down 15 percent)
• Maxillofacial surgery (195,000, up 125 percent)
• Scar revision (175,000, up 9 percent)
• Hand surgery (120,000, up 13 percent)
Breast reconstruction rates continue to rise, with more than 96,000 procedures performed last year, up 3 percent since 2010.
